The Society of Hematologic Oncology invites industry supporters to participate during the 2018 annual meeting. The program affords our industry partners the opportunity to interact with more than 1,200 of the world’s leaders in the hematology/oncology field.
For more information regarding exhibit and support opportunities, just click the following link to download the Industry Prospectus and individual Applications.
You may also contact Belinda Melder, the industry coordinator for the conference at 1.281.364.7387 x201 or via email at email@example.com. If you have already reserved an exhibit space or would like more information about exhibit services or products, you may connect directly to Freeman Online to help you prepare for a successful face-to-face event.
The conference organizing committee wishes to express appreciation to the following companies for their commitment to continuing medical education by providing educational grants or donations in support of this symposium:
AbbVie • Amgen • AstraZeneca • Celgene Corporation • Gilead Sciences, Inc. • Janssen Biotech, Inc.
Astellas Pharma US, Inc. • Epizyme, Inc. • Jazz Pharmaceuticals, Inc. • Pfizer • Seattle Genetics, Inc.
The conference committee wishes to express appreciation to the following companies:
Celgene • Gilead Sciences, Inc • Haymarket Medical Education • MediCom Worldwide, Inc. • Pfizer • Pharmacyclics LLC • Seattle Genetics, Inc
AbbVie • Adaptive Biotechnologies • Agios Pharmaceuticals • Alexion • Astellas Pharma US, Inc. • Bayer • Bristol-Myers Squibb • BMS/Pfizer • Daiichi Sankyo, Inc. • Genentech • Jazz Pharmaceuticals, Inc. • Kartos Therapeutics, Inc. • Karyopharm Therapeutics • Kite, a Gilead Company • Merck & Co., Inc • Novartis Oncology • Shire • SkylineDx • Sunesis Pharmaceuticals, Inc. • Takeda Oncology • Teva Oncology
Astex Pharmaceuticals • Elsevier • MD Anderson Cancer Center